03 December Half Yearly Report
19 November Investor results presentation
13 November Directorate Change
22 October Trading Update & Notice of Results
03 October Director/PDMR Dealing
29 August ShareSoc Growth Company Seminar
28 August Result of AGM
28 August AGM Statement
Delivering on our growth strategy
08 August Director/PDMR Dealing
24 July Posting of Annual Report and Notice of AGM
11 July Director/PDMR Dealing
09 July Holding(s) in Company
09 July Directorate Change
09 July Final Results
Notice of AGM
13 June Notice of Results
Analyst and Investor Briefing
10 June Holding(s) in Company
10 June Holding(s) in Company
07 June Holding(s) in Company
06 June Holding(s) in Company
06 June Holding(s) in Company
06 June Director/PDMR Dealing
06 June Appointment of Non-Executive Director
05 June Result of General Meeting and Open Offer
23 May ShareSoc Growth Company Seminar
20 May Strategic Investment, Placing and Open Offer to raise up to £6.0 million
Notice of General Meeting
09 April Trading Update
21 March Holding(s) in Company
21 February Holding(s) in Company
20 February Sale of Strategic Investment in Jellagen
18 February Presenting at the Hardman Investor Forum
04 February Visit from Local Constituency Member of Scottish Parliament
31 January ChondroMimetic® Update
Distribution Agreement with Indonesian Partner and Update on CE Mark Process
16 January Director / PDMR Dealing
15 January New Manufacturing Agreement for Excellagen® Collagen Wound Healing Matrix
07 January Award of £1.54 million Scottish Enterprise Grant
Non-Dilutive Funding to Support Growth Strategy